Masimo Reschedules Release Of Third Quarter 2012 Financial Results And Associated Conference Call To Thursday, November 1st Due To Hurricane Sandy

IRVINE, Calif., Oct. 29, 2012 /PRNewswire/ --  Masimo (NASDAQ: MASI) announced today that due to Hurricane Sandy it has rescheduled release of its third quarter 2012 financial results and associated conference call from Tuesday, October 30, 2012, to Thursday, November 1, 2012.

Masimo will release its financial results for the period ended September 29, 2012 after the market closes on November 1, 2012 and conduct a conference call to review the results at 1:30 p.m. PT ( 4:30 p.m. ET). The call will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.

Masimo made the change to accommodate members of the investor and financial analyst community being impacted by possible sustained disruption from Hurricane Sandy.

A live webcast of the conference call will be available online from the investor relations page of the company's corporate website at www.masimo.com. The dial-in numbers are [phone] for domestic callers and [phone] for international callers. The reservation code for both dial-in numbers is 38439591. After the live webcast, the call will be available on Masimo's website through December 1, 2012. In addition, a telephonic replay of the call will be available through November 15, 2012. The replay dial-in numbers are [phone] for domestic callers and [phone] for international callers. Please use reservation code 38439591.

About MasimoMasimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET ^®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET ^® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET ^® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb ^®), oxygen content (SpOC ^TM), carboxyhemoglobin (SpCO ^®), methemoglobin (SpMet ^®), and Pleth Variability Index (PVI ^®), in addition to SpO ₂, pulse rate, and perfusion index (PI). In 2008, Masimo introduced Patient SafetyNet™, a remote monitoring and wireless clinician notification system designed to help hospitals avoid preventable deaths and injuries associated with failure to rescue events. In 2009, Masimo introduced rainbow ^® Acoustic Monitoring ^TM, the first-ever noninvasive and continuous monitoring of acoustic respiration rate (RRa™).  Masimo's rainbow ^® SET ^® technology platform offers a breakthrough in patient safety by helping clinicians detect life-threatening conditions and helping guide treatment options. In 2010, Masimo acquired SEDLine ^®, a pioneer in the development of innovative brain function monitoring technology and devices. And in 2012, Masimo acquired the assets of Spire Semiconductor, LLC, a maker of advanced light emitting diode (LED) and other advanced component-level technologies; and PHASEIN AB, a developer and manufacturer of ultra-compact mainstream and sidestream capnography, multigas analyzers, and handheld capnometry solutions. Masimo SET ^® and Masimo rainbow ^® SET ^® technologies also can be found in over 100 multiparameter patient monitors from over 50 medical device manufacturers around the world. Founded in 1989, Masimo has the mission of "Improving Patient Outcome and Reducing Cost of Care ... by Taking Noninvasive Monitoring to New Sites and Applications ^®." Additional information about Masimo and its products may be found at www.masimo.com.

Contact:                                                                 Sheree Aronson [phone]  [e-mail]                                                                     

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, and SEDLine  are trademarks or registered trademarks of Masimo Corporation.

SOURCE Masimo

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.